Feek C M, Sawers J S, Irvine W J, Beckett G J, Ratcliffe W A, Toft A D
N Engl J Med. 1980 Apr 17;302(16):883-5. doi: 10.1056/NEJM198004173021602.
We assessed the efficacy of the combination of propranolol and potassium iodide in the preparation of patients with Graves' disease for thyroid surgery. Potassium iodide was given orally in a dose of 60 mg three times a day for 10 days before operation in 10 patients who were already receiving propranolol. In contrast to previous experience with either drug used singly, the combined regimen caused a significant fall in mean serum total thyroxine and triiodothyronine to levels in the euthyroid range before operation (P less than 0.001). There was also a significant fall (P less than 0.05) before operation and transient rise after operation in serum reverse triiodothyronine. These preliminary results suggest that the combination of potassium iodide and propranolol may prove to be the optimum preoperative preparation for patients with Graves' disease.
我们评估了普萘洛尔与碘化钾联合用药在格雷夫斯病患者甲状腺手术术前准备中的疗效。在10例已服用普萘洛尔的患者中,术前10天口服碘化钾,剂量为60毫克,每日3次。与以往单独使用这两种药物的经验不同,联合用药方案使术前平均血清总甲状腺素和三碘甲状腺原氨酸显著下降至正常甲状腺功能范围(P<0.001)。术前血清反三碘甲状腺原氨酸也显著下降(P<0.05),术后短暂升高。这些初步结果表明,碘化钾和普萘洛尔联合使用可能被证明是格雷夫斯病患者最佳的术前准备方法。